1037759-77-5

Basic information

• Product Name: 6-(5-carbamoyl-2-fluorobenzyl)-4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylic acid
• Synonyms: 6-(5-carbamoyl-2-fluorobenzyl)-4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylic acid
• CAS NO: 1037759-77-5
• Molecular Weight: 463.397
• Mol File: 1037759-77-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-(5-carbamoyl-2-fluorobenzyl)-4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(5-carbamoyl-2-fluorobenzyl)-4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylic acid(1037759-77-5)
• EPA Substance Registry System: 6-(5-carbamoyl-2-fluorobenzyl)-4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylic acid(1037759-77-5)

Safety Data

• Hazardous Substances Data: 1037759-77-5(Hazardous Substances Data)

Upstream product

• 555155-07-2 4-fluorobenzofuran-7-carbaldehyde 
• 253429-18-4 2-(2-bromo-4-fluorophenol) acetaldehyde diethyl acetal 
• 1037763-91-9 ethyl 2-azido-3-(4-fluorobenzofuran-7-yl)-3-hydroxypropanoate 
• 1037763-99-7 ethyl 4-fluoro-8-iodo-6H-furo[2,3-e]indole-7-carboxylate 
• 1037764-16-1 4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylic acid 
• 1037764-11-6 ethyl 4-fluoro-8-(2-oxo-1,2-dihydropyridin-3-yl)-6H-furo[2,3-e]indole-7-carboxylate 
• 1037764-20-7 4-fluorofuro[2,3-e]pyrido[3',2':5,6]pyrano[3,4-b]indol-7(6h)-one 
• 253429-31-1 4-fluoro-7-bromo-benzo(b)furan 
• 147460-41-1 2-bromo-5-fluorophenol 

Relevant articles and documents

Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics

HCV infections are the leading causes for hepatocellular carcinoma and liver transplantation in the United States. Recent advances in drug discovery have identified direct acting antivirals which have significantly improved cure rates in patients. Current